ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2022.0.179 2022.0.179 2023-08-312023-08-31trueNo description of principal activitytrue2022-09-0111true 01128997 2022-09-01 2023-08-31 01128997 2021-09-01 2022-08-31 01128997 2023-08-31 01128997 2022-08-31 01128997 c:Director1 2022-09-01 2023-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar 2023-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar 2022-08-31 01128997 d:CurrentFinancialInstruments 2023-08-31 01128997 d:CurrentFinancialInstruments 2022-08-31 01128997 d:CurrentFinancialInstruments d:WithinOneYear 2023-08-31 01128997 d:CurrentFinancialInstruments d:WithinOneYear 2022-08-31 01128997 d:ShareCapital 2023-08-31 01128997 d:ShareCapital 2022-08-31 01128997 d:RetainedEarningsAccumulatedLosses 2023-08-31 01128997 d:RetainedEarningsAccumulatedLosses 2022-08-31 01128997 c:OrdinaryShareClass1 2022-09-01 2023-08-31 01128997 c:OrdinaryShareClass1 2023-08-31 01128997 c:OrdinaryShareClass1 2022-08-31 01128997 c:EntityNoLongerTradingButTradedInPast 2022-09-01 2023-08-31 01128997 c:FRS102 2022-09-01 2023-08-31 01128997 c:AuditExempt-NoAccountantsReport 2022-09-01 2023-08-31 01128997 c:FullAccounts 2022-09-01 2023-08-31 01128997 c:PrivateLimitedCompanyLtd 2022-09-01 2023-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2022-09-01 2023-08-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 01128997









CYBERMED (U.K.) LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2023

 
CYBERMED (U.K.) LIMITED
REGISTERED NUMBER: 01128997

BALANCE SHEET
AS AT 31 AUGUST 2023

2023
2022
Note
£
£

Fixed assets
  

Intangible assets
 5 
17,021
28,346

  
17,021
28,346

  

Creditors: amounts falling due within one year
 6 
(155,289)
(143,366)

Net current liabilities
  
 
 
(155,289)
 
 
(143,366)

Total assets less current liabilities
  
(138,268)
(115,020)

  

Net liabilities
  
(138,268)
(115,020)


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
(138,368)
(115,120)

  
(138,268)
(115,020)


Page 1

 
CYBERMED (U.K.) LIMITED
REGISTERED NUMBER: 01128997
    
BALANCE SHEET (CONTINUED)
AS AT 31 AUGUST 2023

For the year ended 31 August 2023 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 22 January 2024.




M B Hughes
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

1.


General information

The Company is a private company, limited by shares, incorporated and domiciled in England within the United Kingdom, registration number 01128997. The Company's registered office is 18 Hartford Close, Harborne, Birmingham, B17 8AU.
The financial statements are presented in sterling which is the functional currency of the company and the financial statements are rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

Cash flow
Under Financial Reporting Standard 102, the company is exempt from the requirement to prepare a cash flow statement on the grounds that it qualifies as a small company.

 
2.2

Going concern

The company has made losses and as such has net liabilities at the balance sheet date.  The main creditors of the company are the director and shareholders who intend to continue to support the company for the foreseeable future and the director therefore considers it appropriate to prepare the accounts on a going concern basis.

 
2.3

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.4

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.5

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument.
Page 3

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

2.Accounting policies (continued)


2.5
Financial instruments (continued)


Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.
Page 4

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

2.Accounting policies (continued)


2.5
Financial instruments (continued)


Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2022 - 1).


4.


Taxation

The company has trading tax losses of £113,513 (2022 - £110,256) available to offset against future trading profits.

Page 5

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

5.


Intangible assets




Patents

£



Cost


At 1 September 2022
50,996



At 31 August 2023

50,996



Amortisation


At 1 September 2022
22,650


Charge for the year on owned assets
11,325



At 31 August 2023

33,975



Net book value



At 31 August 2023
17,021



At 31 August 2022
28,346




6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Other creditors
154,569
142,646

Accruals and deferred income
720
720

155,289
143,366



7.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



100 (2022 - 100) Ordinary shares of £1.00 each
100
100


Page 6

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

8.


Related party transactions

As at 31 August 2023 amounts due to the director was £94,267 (2022 - £82,374) and amounts due to shareholders were £60,272 (2022 - £60,272).
All loans are interest free and repayable on demand.

 
Page 7